ABSTRACT. The administration of growth hormone (GH) in conjunction with calcitriol in uremia may increase urinary calcium and decrease renal phosphate excretion, which could have an adverse effect on the kidney in chronic renal insufficiency. The effect of 40 d of ovine GH, calcitriol, and the combination of G H and calcitriol on mineral excretion was studied in rapidly growing uremic rats. Uremia was produced by 75% nephrectomy, and the animals were fed a diet containing 8% protein with equal quantities of calcium (0.6%) and phosphate (0.6%). The uremic rats treated with ovine G H were significantly longer and heavier than the uremic control rats and the uremic rats treated with calcitriol alone. However, the combination of calcitriol and G H abolished the beneficial effect of G H on growth and increased urinary calcium excretion 4-fold over uremic controls whether expressed as calcium excretion per 100 g body weight, urine calcium to creatinine ratio, or as fractional calcium excretion. Calcitriol therapy alone also significantly increased calcium excretion, but not to the extent that the combination therapy did. This increased urinary calcium excretion in the G H plus calcitriol group was not associated with an increase in calcium and sodium intake, plasma ionized calcium, or urinary sodium excretion. The calcium content of the femurs from all uremic rat groups was significantly lower than that of the sham control rats; however, there was also no further decrease in bone calcium content in the G H plus calcitriol group compared with uremic controls. This indicated that bone was not the source of this excess urinary calcium. Our data indicate that the combination of G H and calcitriol significantly increases urinary calcium excretion in growing uremic rats. These results suggest the need to monitor such untoward side effects in children with chronic renal failure who receive this combination of therapies. (Pediatr Res 30: 528-533,1991) Abbreviations SC, sham control UC, uremic control
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Although the mechanisms underlying the inhibitory effects of uremia on growth remain unclear, administration of supraphysiological doses of G H to uremic animals (14-16) and to a small number of uremic children (171, over relatively short intervals, has been shown to improve growth. Whether this will significantly improve the final adult stature remains to be determined.
Treatment of chronic renal failure in children usually includes one of the polar vitamin D metabolites. The effects of G H alone or in combination with calcitriol administration on renal electrolyte handling and mineral balance in uremia are largely unknown. However, this information is vitally important. Increased serum concentrations of calcium and phosphate are associated with a number of problems in renal failure including calciphylaxis, pruritis, aggravation of secondary hyperparathyroidism, and possibly progression of renal failure (1 8). However, several lines of evidence have been recently presented that suggested that calcium and phosphate disorders play a secondary and minor role in the progression of renal failure.
If hypercalciuria is significantly aggravated by vitamin D combined with GH therapy, it may lead to urolithiasis, which would be an important complication to be further defined in humans. Therefore, we investigated the effects of supraphysiologic doses of GH alone and in combination with calcitriol on sodium, calcium, magnesium, and phosphate homeostasis using a 75% nephrectomy uremic, weanling rat model.
MATERIALS AND METHODS
The GH used in this study was oGH, supplied by the National The left femur was removed after the rats were killed and was was obtained by calculating the average daily food consumption The mean creatinine clearance in each uremic group was and dividing this by the average weight for the rat over the time significantly reduced when compared with the sham-operated of the experiment.
control group. There were no significant differences between the At completion of the 40-d experimental period, the rats were mean creatinine clearances of the uremic groups (Fig. 2) . The placed in individual Nalgene metabolic cages (Sybron Corp., sham-operated control animals ate significantly more food over Rochester, NY), and fasting (water a d libitum) 24-h urine collec-the course of the experiment than the uremic animals ( Fig. 3) tions were taken. After the urine collections, the rats were anes-and, therefore, took in more minerals than the uremic animals thetized and exsanguinated by cardiac puncture.
( Table 3 ). There was no difference in the total food intake Plasma ionized and total calcium concentration was measured between the various uremic groups. The average daily food intake immediately after separation from the cells using a Nova 7 per 100 g body weight was not different between the groups. Electrolyte Analyzer (Nova Biomedical, Waltham, MA). Serum Uremic rats treated for 40 d with ovine G H therapy were and urine collected for electrolyte analysis were stored at -20°C. heavier ( Fig. 4 and Table 4 ) and longer (Fig. 5 , Table 4 ) when Urinary sodium was measured using a Beckman E4A analyzer compared with uremic control rats, an effect that has been shown (Beckman Instruments, Inc., Brea, CA). Serum and urine inor-previously for both rat and human GH. Calcitriol alone had no ganic phosphorus were measured using the method of Baginski effect on growth in uremic rats and abolished the beneficial et al. (19) . Serum and urine magnesium and calcium were growth effect of GH. measured using a Perkin-Elmer model 5000 atomic absorption
The serum concentrations of total calcium, ionized calcium, spectrophotometer (Perkin-Elmer Corp., Nonvalk, CT) (20). Cre-magnesium, and phosphate are shown in Table 5 . There was no atinine was measured using a Beckman Creatinine Analyzer 11. statistically significant difference between the serum concentraCreatinine clearance was calculated using the standard formula. tions of these ions among the uremic groups. The mean serum The percent of fractional excretion (%FE) of an electrolyte was total calcium in the U D group was significantly higher than the calculated from the following equation: %FE, = [(U, times PC,) mean of the SC group. The mean serum phosphate concentration divided by (P, times Uc,)] x 100, where x is the electrolyte, Cr of the UDGH group was significantly greater than that of the SC Fig. 6 . Urinary sodium and calcium to creatinine ratios. Sodium to creatinine ratio (NuICr) in mmol/mg. Calcium to creatinine ratio (Gal C'r) in mg/mg. $ Significantly larger than all other groups.
group. The mean serum magnesium concentrations of the UC, UD, and UDGH groups were higher than that of the SC group. The 24-h urinary excretion of calcium per 100 g body wt is shown in Table 6 . The UDGH group excreted a significantly greater amount of calcium per day than all other groups. The 24-h mean urinary calcium excretion of the UD group was significantly greater than that of the UC and SC groups. Factoring the 24-h urinary calcium by the urinary creatinine (Fig. 6 ) revealed a similar pattern of significantly increased calcium excretion in the UDGH group compared with all the other groups and also an increased calcium excretion in the UD group compared with the UC and SC groups. The sodium/creatinine ratio and the sodium excretion per d per 100 g body wt in the UD and UDGH groups were not different from those of the other groups, indicating that the greater calcium excretion in the UD and UDGH groups was not secondary to increased sodium excretion. The fractional excretion of calcium (Table 7 , Fig. 7 ) was significantly higher in the UDGH rats when compared with all other groups.
FEp was significantly elevated in the UC, UD, and UDGH groups compared with that of the SC group. There was no statistical difference in the FEp between the uremic groups ( Table  7) . The FEp in the UGH group was the lowest among the uremic groups and was not statistically greater than that of the sham controls. This suggests that G H can increase phosphate reabsorption in uremia, which could be an undesirable side effect of G H therapy in chronic renal failure.
The fractional excretion of magnesium was elevated in each of the uremic groups compared with that of the SC group; however, the difference between the means reached significance only for the UC, UD, and UDGH groups. There was no significant difference in fractional excretion of magnesium between the uremic groups ( Table 7) .
Bone mineral analysis. Bone weight and mineral content were normalized to 100 g body weight, and the results are presented in Table 8 . The mean desiccated femur weights of the UGH, UD, and UDGH groups were significantly heavier than that of the SC group. Furthermore, the mean desiccated femur weight of the UDGH group was significantly greater than that of the UC group. However, the mean calcium content of the desiccated bones was significantly greater in the SC group compared with the means of the UC and UGH groups. The mean calcium content of dry bone in the UD group was significantly greater than that of the UGH group. There was no difference in the mean dry bone calcium content of the UDGH group and those 532 KAINER ET AL. i Values on top are expressed as mmol/g dry bone wt; values in parentheses are expressed as mg/g dry bone wt.
$ Significantly greater than UC and UGH.
4 Significantly larger than SC only.
11 Significantly greater than SC, UC, and UGH.
9 Significantly greater than UGH only. **Significantly larger than both SC and UC.
of the other groups. Each of the uremic groups had a mean femur magnesium content that was greater than that of the SC group, but this was statistically significant only for the UDGH group. There was no difference in femur magnesium content between the uremic groups.
DISCUSSION
The one-stage, 75% nephrectomized, chronic renal insufficiency weanling rat model allows experimental observation during the prepubertal period and through the pubertal rapid growth phase. Thus, the model simulates the pediatric patient with chronic renal insufficiency. To improve survival in our rats and to reduce the potential deleterious effects of a high protein diet and excessive phosphorus intake on the remnant kidney, all rats in our study were fed a diet containing 8% protein with equal quantities of calcium and phosphorus (14) . Diets containing a relatively high protein content (over 20% protein) have been shown consistently to hasten the progression of remnant kidney sclerosis in uremic rats (22, 23) . Diets containing less than 6% protein are deficient, but an 8% protein diet provides an adequate amount of protein to allow moderate weight gain (24) . For maximal weight gain, a higher protein intake is necessary in uremic rats. It has been suggested that a high phosphate intake is associated with accelerated deterioration of renal function in uremic rats (25) . However, protein intake appears to be much more important than any other nutrient in accelerating renal damage (24) .
This study showed, as have others (14-1 6) , that the administration of GH to uremic, weanling rats can improve their growth, an effect also noted in children with chronic renal failure (17). Calcitriol administration did not improve growth in these uremic rats, although it has been shown to improve growth in children with chronic renal failure (5). It is unclear why calcitriol did not improve growth, but it may be related to the low phosphorus content of the diet, which prevented a fall in calcitriol production, as has been shown in children with renal failure on restricted phosphorus diets (26) . Thus, by restricting dietary phosphorus, these animals may not have needed supplemental calcitriol. Surprisingly, the growth-enhancing effect of G H therapy was lost when calcitriol was added to the regimen. The mechanism for this lack of effect is unclear.
The combination of calcitriol and G H led to marked hypercalciuria, whether expressed as calcium excretion per 100 g body wt, as the ratio of calcium to creatinine, or as the fractional excretion of calcium. Calcitriol has clearly been associated with hypercalciuria in renal failure (1 l), and this was observed in the uremic rats given calcitriol alone. GH has also been shown to increase urinary calcium excretion both in humans (27) and in animals (28) . This may be due, in part, to an increase in renal 1-a-hydroxylase activity with increased production of calcitriol and adsorption of dietary calcium (29, 30) . GH administration alone increased urinary calcium excretion compared with the UC and the SC animals, but this did not reach statistical significance.
Increased urinary calcium excretion can result from increased serum ionized calcium concentrations, resulting in an increased filtered load. However, there was no difference in the mean serum ionized calcium concentrations between any of the groups. Another cause of increased urinary calcium excretion is increased dietary calcium and/or sodium intake (31) . However, in our study, this was not the case because there was no difference in dietary intakes between uremic animal groups. In fact, the SC animals ingested more calcium and sodium than any of the uremic groups, yet this group had the lowest urinary calcium excretion. Therefore, increased urinary sodium excretion was not the cause of the hypercalciuria.
The source of the increased urinary calcium is next examined. The bone did not appear to be the source because the calcitriol (UD) group had the highest and the calcitriol plus GH (UDGH) group had the next highest bone calcium content of the uremic animals. Still, even these two groups had significantly less calcium compared with the SC group, underscoring the deleterious effect of uremia on bone calcification. On the other hand, bone magnesium content was increased in the uremic groups compared with the SC group, an effect previously noted (32) . Further studies are necessary to elucidate whether the hypercalciuria is secondary to increased intestinal absorption, renal "leak," or both.
Another effect of G H on the kidney that could be deleterious in renal failure is the enhancement of phosphate reabsorption (27, 28) . FE, was increased in all of the uremic rats. GH administration appeared to blunt this increased phosphate excretion in uremia because this group (UGH) had the smallest increase in FE, and the phosphate excretion of the UGH group was not statistically different from that of the SC group. The addition of calcitriol to G H abolished this antiphosphaturic effect of GH. However, this group (UDGH) had the highest serum phosphate concentration. This elevated phosphate concentration was probably due to increased intestinal absorption under the influence of calcitriol and GH because the renal excretion was as great as in the UC group.
In conclusion, our studies indicate that marked hypercalciuria occurs in response to combined GH and calcitriol treatment in uremic rats. This complication, together with the potential risk
